PMID- 31852767 OWN - NLM STAT- MEDLINE DCOM- 20210531 LR - 20210531 IS - 1098-660X (Electronic) IS - 0095-1137 (Print) IS - 0095-1137 (Linking) VI - 58 IP - 3 DP - 2020 Feb 24 TI - Cerebrospinal Fluid Findings Are Poor Predictors of Appropriate FilmArray Meningitis/Encephalitis Panel Utilization in Pediatric Patients. LID - 10.1128/JCM.01592-19 [doi] LID - e01592-19 AB - Molecular testing of cerebrospinal fluid (CSF) using the BioFire FilmArray meningitis/encephalitis (FA-M/E) panel permits rapid, simultaneous pathogen detection. Due to the broad spectrum of targeted organisms, FA-M/E testing may be restricted to patients with abnormal CSF findings. We sought to determine if restriction is appropriate in our previously healthy and/or immunocompromised pediatric patients. FA-M/E was ordered on 1,025 CSF samples from 948 patients; 121 (11.8%) specimens were FA-M/E positive. Of these, 89 (73.6%) were virus positive, and 30 (24.8%) were bacterium positive. The most common targets detected were enterovirus (n = 38), human herpesvirus 6 (HHV-6) (n = 30), and Streptococcus pneumoniae (n = 14). Pleocytosis with white blood cell (WBC) levels of >/=5 cells/mm(3) and >/=10 cells/mm(3) were found in 33.1% and 24.3% of all specimens, respectively. Using WBC levels of >/=5 cells/mm(3), 63.4% (59/93) of positive specimens exhibited pleocytosis, compared to 29.5% (233/789) of negative specimens. Among positive specimens, 54.4% (37/68) of viral and 87% (20/23) of bacterial cases had pleocytosis. The use of a pleocytosis cutoff of >/=10 cells/mm(3) would have missed an additional enterovirus, one cytomegalovirus (CMV), and two HHV-6 diagnoses. CSF glucose and protein levels were normal for 83/116 (75.2%) and 51/116 (44%) positive specimens. Abnormal glucose in combination with WBC levels of >/=10 cells/mm(3) showed high specificity (94.5%) and was a better predictor of FA-M/E positivity than abnormal protein. Sensitivity and positive predictive values were <90% for all biomarkers. CSF pleocytosis and abnormal glucose/protein were poor predictors of FA-M/E. Restricting FA-M/E orders based on pleocytosis or other abnormal parameters would have resulted in missed diagnostic opportunities, particularly for the detection of viruses in both previously healthy and immunocompromised patients. CI - Copyright (c) 2020 American Society for Microbiology. FAU - Precit, Mimi R AU - Precit MR AUID- ORCID: 0000-0002-0720-8643 AD - Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA. FAU - Yee, Rebecca AU - Yee R AD - Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA. FAU - Pandey, Utsav AU - Pandey U AD - Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA. FAU - Fahit, Margil AU - Fahit M AD - Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA. FAU - Pool, Cheryl AU - Pool C AD - Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA. FAU - Naccache, Samia N AU - Naccache SN AD - LabCorp Diagnostic Laboratories, Seattle, Washington, USA. FAU - Dien Bard, Jennifer AU - Dien Bard J AD - Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, California, USA jdienbard@chla.usc.edu. AD - Keck School of Medicine, University of Southern California, Los Angeles, California, USA. LA - eng PT - Journal Article DEP - 20200224 PL - United States TA - J Clin Microbiol JT - Journal of clinical microbiology JID - 7505564 SB - IM MH - Bacteria MH - Cerebrospinal Fluid MH - Child MH - *Encephalitis/microbiology/virology MH - Female MH - Humans MH - Male MH - *Meningitis/microbiology/virology MH - Molecular Diagnostic Techniques MH - *Viruses PMC - PMC7041564 OTO - NOTNLM OT - CSF parameters OT - encephalitis OT - meningitis OT - molecular OT - pediatric EDAT- 2019/12/20 06:00 MHDA- 2021/06/01 06:00 PMCR- 2020/08/24 CRDT- 2019/12/20 06:00 PHST- 2019/09/24 00:00 [received] PHST- 2019/12/17 00:00 [accepted] PHST- 2019/12/20 06:00 [pubmed] PHST- 2021/06/01 06:00 [medline] PHST- 2019/12/20 06:00 [entrez] PHST- 2020/08/24 00:00 [pmc-release] AID - JCM.01592-19 [pii] AID - 01592-19 [pii] AID - 10.1128/JCM.01592-19 [doi] PST - epublish SO - J Clin Microbiol. 2020 Feb 24;58(3):e01592-19. doi: 10.1128/JCM.01592-19. Print 2020 Feb 24.